Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506

Kidney International

Volumn 50, Issue 4, 1996, Pages 1110-1117

  Andoh, Takeshi F ^a   Burdmann, Emmanuel A ^b   Fransechini, Nora ^b   Houghton, Donald C ^b   Bennett, William M ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CYCLOSPORIN A; IMMUNOPHILIN; MAGNESIUM; RAPAMYCIN; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULOPATHY; HYPOMAGNESEMIA; KIDNEY CALCIFICATION; MALE; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0029832389     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.417     Document Type: Article

References (42)

1. KAHAN BD: Cyclosporine. N Engl J Med 321:1725-1738, 1989
2. FEUTREN G, MIHATSCH MJ: Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases. N Engl J Med 326:1654-1660, 1992
3. MYERS BD, SIBLEY R, NEWTON L, TOMLANOVICH SJ, BOSHKOS C, STINSON E, LUETCHER JA, WHITNEY DJ, KRANY D, COPLON NS, PERLROTH MG: The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 33:590-600, 1988
4. BENNETT WM, BURDMANN EA, ANDOH TF, HOUGHTON DC, LINDSLEY J, ELZINGA LW: Nephrotoxicity of immunosuppressive drugs. Nephrol Dial Transplant 9(Suppl 4):141-145, 1994
5. AL KHURSANY I, THOMAS TH, HARRISON K, WILKINSON R: Reduced erythrocyte and leukocyte magnesium is associated with cyclosporin treatment and hypertension in renal transplant patients. (see comments) Nephrol Dial Transplant 7:251-255, 1992
6. NOZUE T, KOBAYASHI A, KODAMA T, UEMASU F, ENDOH H, SAKO A, TAKAGI Y: Pathogenesis of cyclosporine-induced hypomagnesemia. J Pediatr 120:638-640, 1992
7. STARZU TE, TODO S, FUNG J, DEMETRIS AJ, VENKATARAMMAN R, JAIN A: FK 506 for liver, kidney, and pancreas transplantation. Lancet 2:1000-1004, 1989
8. MURGIA MG, JORDAN S, KAHAN BD: The side effect profile of sirolimus-A phase 1 study in quiescent cyclosporine-prednisone-treated renal transplant patients. Kidney Int 49:209-216, 1996
9. LIU J, FARMER JDJ, LANE WS, FRIEDMAN J, WEISSMAN I, SCHREIBER SL: Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66:807-815, 1991
10. FRUMAN DA, KLEE CB, BIERER BE, BURAKOFF SJ: Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci USA 89:3686-3690, 1992
11. + -ATPase activity by FK506 involves calcineurin. Kidney Int 46:647-652, 1994
12. RYFFEL B, WEBER E, MIHATSCH MJ: Nephrotoxicity of immunosuppressants in rats: Comparison of macrolides with cyclosporin. Exp Nephrol 2:324-333, 1994
13. DIJOSEPH JF, SHARMA RN, CHANG JY: The effect of rapamycin on kidney function in the Sprague-Dawley rat. Transplantation 53:507-513, 1992
14. GOTO S, STEPKOWSKI SM, KAHAN BD: Effect of FK 506 and cyclosporine on heart allograft survival in rats. Transplant Proc 23:529-530, 1991
15. STEPKOWSKI SM, CHEN H, DALOZE P, KAHAN BD: Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat. Transplantation 51:22-26, 1991
16. INAMURA N, NAKAHARA K, KINO T, GOTO T, AOKI H, YAMAGUCHI I, KOHSAKA M, OCHIAI T: Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506. Transplantation 45:206-209, 1988
17. TAMURA K, KOBAYASHI M, HASHIMOTO K, KOJIMA K, NAGASE K: A highly sensitive method to assay FK-506 levels in plasma. Transplant Proc 19(Suppl 6):23-29, 1987
18. CONRAD KP, JOFFE GM, KRUSZYNA H, KRUSZYNA R, ROCHELLE LG, SMITH RP, CHAVEZ JE, MOSHER MD: Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 7:566-571, 1993
19. ANDOH TF, BURDMANN EA, LINDSLEY J, HOUGHTON DC, BENNETT WM: Functional and structural characterisies of experimental FK506 nephrotoxicity. Clin Exp Pharmacol Physiol 22:646-654, 1995
20. BURDMANN EA, ANDOH TF, NAST CC, EVANS A, CONNOR BA, COFFMAN TM, LINDSLEY J, BENNETT WM: Prevention of experimental cyclosporine-induced interstitial fibrosis by Iosartan and enalapril. Am J Physiol 269:F491-F499, 1995
21. KAHAN BD, CHANG JY, SEHGAL SN: Preclinical evaluation of a new potent immunosuppressive agent, rapamycin. Transplantation 52:185-191, 1991
22. DAWSON TM, STEINER JP, DAWSON VL, DINERMAN JL, UHL GR, SNYDER SH: Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. (see comments) Proc Natl Acad Sci USA 90:9808-9812, 1993
23. 2+. Circ Res 74:477-484, 1994
24. DIEDERICH D, YANG Z, LUSCHER TF: Chronic cyclosporine therapy impairs endothelium-dependent relaxation in the renal artery of the rat. J Am Soc Nephrol 2:1291-1297, 1992
25. ROULLET JB, XUE H, MCCARRON DA, HOLCOMB S, BENNETT WM: Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest 93:2244-2250, 1994
26. MONCADA S, REFS DD, SCHULZ R, PALMER RM: Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA 88:2166-2170, 1991
27. SCHREIBER SL: Immunophilin-sensitive protein phosphatase action in cell signaling pathways. Cell 70:365-368, 1992
28. GALLEGO MJ, LOPEZ FARRE A, RIESCO A, MONTON M, GRANDES SM, BARAT A, HERNANDO L, CASADO S, CARAMELO CA: Blockade of endothelium-dependent responses in conscious rats by cyclosporin A: Effect of L-arginine. Am J Physiol 264:H708-H714, 1993
29. DE NICOLA L, THOMSON SC, WEAD LM, BROWN MR, GABBAI FB: Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 92:1859-1865, 1993
30. GARDNER MP, HOUGHTON DC, ANDOH TF, LINDSLEY J, BENNETT WM: Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition. Transplantation (in press)
31. SENEY FDJ, MARVER D: Protein intake and cation transport in the loop of Henle. J Lab Clin Med 114:587-594, 1989
32. AL GHAMDI SM, CAMERON EC, SUTTON RA: Magnesium deficiency: Pathophysiologic and clinical overview. Am J Kidney Dis 24:737-752, 1994
33. ROCK E, ASTIER C, LAB C, VIGNON X, GUEUX E, MOTTA C, RAYSSIGUIER Y: Dietary magnesium deficiency in rats enhances free radical production in skeletal muscle. J Nutr 125:1205-1210, 1995
34. QUAMME GA: Control of magnesium transport in the thick ascending limb. Am J Physiol 256:F197-F210, 1989
35. CONTE G, DAL CANTON A, SABBATINI M, NAPODANO P, DE NICOLA L, GIGLIOTTI G, FUIANO G, TESTA A, ESPOSITO C, Russo D, ANDREUCCI VE: Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects. Kidney Int 36:1086-1092, 1989
36. ELZINGA LW, ROSEN S, BENNETT WM: Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: Role of sodium intake. J Am Soc Nephrol 4:214-221, 1993
37. YOUNG BA, BURDMANN EA, JOHNSON RJ, ANDOH T, BENNETT WM, COUSER WG, ALPERS CE: Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy. Kidney Int 48:431-438, 1995
38. ANDOH TF, BURDMANN EA, LINDSLEY J, HOUGHTON DC, BENNETT WM: Enhancement of FK506 nephrotoxicity by sodium depletion in an experimental rat model. Transplantation 57:483-489, 1994
39. KON V, HUNLEY TE, FOGO A: Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats. Transplantation 60:89-95, 1995
40. ROSEN S, GREENFELD Z, BREZIS M: Chronic cyclosporine-induced nephropathy in the rat. A medullary ray and inner stripe injury. Transplantation 49:445-452, 1990
41. JORDAN ML, SHAPIRO R, VIVAS CA, SCANTLEBURY VP, DARRAS FS, CARRIERI G, MCCAULEY J, DEMETRIS AJ, RANDHAWA P, JENSEN C, HAKALA TR, FUNG JJ, STARZL TE: FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression. Transplant Proc 25:638-640, 1993
42. JAPANESE STUDY OF FK 506 ON KIDNEY TRANSPLANTATION: Results of late phase II study. Transplant Proc 25:649-654, 1993